A. Naka

589 total citations
16 papers, 489 citations indexed

About

A. Naka is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, A. Naka has authored 16 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Physiology. Recurrent topics in A. Naka's work include Drug Transport and Resistance Mechanisms (4 papers), Adipose Tissue and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). A. Naka is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Adipose Tissue and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). A. Naka collaborates with scholars based in Japan and Australia. A. Naka's co-authors include Kaoruko Iida, Yuri Sakamoto, Kazuo Kondo, Masaki Horie, Shingo Kamoshida, Masatsugu Ema, Satoru Takahashi, Naoshi Obara, Shigehiko Imagawa and Ken Matsumoto and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

A. Naka

16 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Naka Japan 13 247 125 84 80 70 16 489
Jipeng Ma China 16 327 1.3× 84 0.7× 133 1.6× 69 0.9× 51 0.7× 29 689
Kyoko Okamoto Japan 12 205 0.8× 119 1.0× 76 0.9× 53 0.7× 55 0.8× 35 554
Bong‐Jo Kim South Korea 11 398 1.6× 72 0.6× 96 1.1× 60 0.8× 63 0.9× 19 607
Ling He China 13 212 0.9× 69 0.6× 126 1.5× 96 1.2× 58 0.8× 25 560
Pei-Fang Hung Taiwan 12 216 0.9× 104 0.8× 134 1.6× 146 1.8× 59 0.8× 13 541
Mary Y. K. Lee Hong Kong 11 253 1.0× 237 1.9× 136 1.6× 49 0.6× 37 0.5× 16 694
Tianluo Lei China 12 307 1.2× 146 1.2× 101 1.2× 38 0.5× 128 1.8× 16 622
S. Le Plénier France 10 194 0.8× 148 1.2× 36 0.4× 53 0.7× 120 1.7× 29 456

Countries citing papers authored by A. Naka

Since Specialization
Citations

This map shows the geographic impact of A. Naka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Naka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Naka more than expected).

Fields of papers citing papers by A. Naka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Naka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Naka. The network helps show where A. Naka may publish in the future.

Co-authorship network of co-authors of A. Naka

This figure shows the co-authorship network connecting the top 25 collaborators of A. Naka. A scholar is included among the top collaborators of A. Naka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Naka. A. Naka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Naka, A., et al.. (2018). Lactate Promotes Myoblast Differentiation and Myotube Hypertrophy via a Pathway Involving MyoD In Vitro and Enhances Muscle Regeneration In Vivo. International Journal of Molecular Sciences. 19(11). 3649–3649. 51 indexed citations
3.
Kamoshida, Shingo, Naoki Ogane, Yoichi Kameda, et al.. (2016). Immunohistochemical expression profiles of solute carrier transporters in alpha‐fetoprotein‐producing gastric cancer. Histopathology. 69(5). 812–821. 13 indexed citations
4.
Naka, A., et al.. (2015). Dietary isoflavone daidzein promotes Tfam expression that increases mitochondrial biogenesis in C2C12 muscle cells. The Journal of Nutritional Biochemistry. 26(11). 1193–1199. 37 indexed citations
5.
Naka, A., Naoki Ogane, Yoichi Kameda, et al.. (2015). Impact of Expression Levels of Platinum-uptake Transporters Copper Transporter 1 and Organic Cation Transporter 2 on Resistance to Anthracycline/Taxane-based Chemotherapy in Triple-negative Breast Cancer. Breast Cancer Basic and Clinical Research. 9. BCBCR.S27534–BCBCR.S27534. 5 indexed citations
6.
Naka, A., Takahiro Shintani, Naoki Ogane, et al.. (2015). Organic cation transporter 2 for predicting cisplatin-based neoadjuvant chemotherapy response in gastric cancer.. PubMed. 5(7). 2285–93. 12 indexed citations
7.
Sawada, Yoko, Yuri Sakamoto, A. Naka, et al.. (2015). Milk-derived peptide Val-Pro-Pro (VPP) inhibits obesity-induced adipose inflammation via an angiotensin-converting enzyme (ACE) dependent cascade. Molecular Nutrition & Food Research. 59(12). 2502–2510. 45 indexed citations
8.
Naka, A., Naoki Ogane, Yoichi Kameda, et al.. (2014). Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancer. Breast Cancer Research and Treatment. 145(1). 101–111. 21 indexed citations
9.
Naka, A., et al.. (2014). High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapy.. PubMed. 4(5). 528–36. 23 indexed citations
10.
Nakagawa, Yoshimi, Aoi Satoh, A. Naka, et al.. (2013). TFE3 Controls Lipid Metabolism in Adipose Tissue of Male Mice by Suppressing Lipolysis and Thermogenesis. Endocrinology. 154(10). 3577–3588. 29 indexed citations
11.
Sakamoto, Yuri, et al.. (2013). Daidzein regulates proinflammatory adipokines thereby improving obesity‐related inflammation through PPARγ. Molecular Nutrition & Food Research. 58(4). 718–726. 60 indexed citations
12.
Naka, A., Kaoruko Iida, Yoshimi Nakagawa, et al.. (2012). TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin. Biochemical and Biophysical Research Communications. 430(2). 664–669. 12 indexed citations
13.
Iwasaki, Hitoshi, A. Naka, Kaoruko Iida, et al.. (2012). TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice. American Journal of Physiology-Endocrinology and Metabolism. 302(7). E896–E902. 29 indexed citations
14.
Horie, Masaki, et al.. (2011). Proteomic Profiling of K-11706 Responsive Proteins. International Journal of Sports Medicine. 32(7). 559–564. 1 indexed citations
15.
Imagawa, Toshiaki, et al.. (2009). Caffeine and Taurine Enhance Endurance Performance. International Journal of Sports Medicine. 30(7). 485–488. 35 indexed citations
16.
Matsumoto, Ken, Naoshi Obara, Masatsugu Ema, et al.. (2009). Antitumor effects of 2‐oxoglutarate through inhibition of angiogenesis in a murine tumor model. Cancer Science. 100(9). 1639–1647. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026